BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Agaimy A. SWI/SNF Complex-Deficient Soft Tissue Neoplasms. Surgical Pathology Clinics 2019;12:149-63. [DOI: 10.1016/j.path.2018.10.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Agaimy A. SWI/SNF-deficient Sinonasal Carcinomas. Adv Anat Pathol 2023;30:95-103. [PMID: 36580412 DOI: 10.1097/PAP.0000000000000372] [Reference Citation Analysis]
2 Wardelmann E, Kuntze A, Hartmann W. Molekularpathologie bei ausgewählten Weichgewebssarkomen: diagnostisch und therapeutisch relevante Aberrationen. Onkologie 2022. [DOI: 10.1007/s00761-022-01296-4] [Reference Citation Analysis]
3 Agaimy A. SWI/SNF-deficient Malignancies: Optimal Candidates for Immune-oncological Therapy? Adv Anat Pathol 2022. [PMID: 36069856 DOI: 10.1097/PAP.0000000000000366] [Reference Citation Analysis]
4 Zullow HJ, Sankar A, Ingram DR, Samé Guerra DD, D'Avino AR, Collings CK, Lazcano R, Wang WL, Liang Y, Qi J, Lazar AJ, Kadoch C. The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma. Mol Cell 2022;82:1737-1750.e8. [PMID: 35390276 DOI: 10.1016/j.molcel.2022.03.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Agaimy A. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview. Head Neck Pathol 2022;16:168-78. [PMID: 35307773 DOI: 10.1007/s12105-022-01416-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
6 Xu W, Dong H, Ru G, Zhao M. ARID1A deficient undifferentiated spindle cell and rhabdoid sarcoma of the prostate: report of a unique case with emphasis on diagnostic implications. Diagn Pathol 2022;17. [DOI: 10.1186/s13000-022-01198-4] [Reference Citation Analysis]
7 Ashour S, Reynolds JP, Mukhopadhyay S, McKenney JK. SMARCA4-Deficient Undifferentiated Tumor Diagnosed on Adrenal Sampling. Am J Clin Pathol 2022;157:140-5. [PMID: 34463317 DOI: 10.1093/ajcp/aqab101] [Reference Citation Analysis]
8 Duan Z, Yao K, Yang S, Qu Y, Ren M, Zhang Y, Fan T, Zhao H, Gao J, Feng J, Fan X, Qi X. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor. Mod Pathol 2022;35:1910-20. [PMID: 35804041 DOI: 10.1038/s41379-022-01127-2] [Reference Citation Analysis]
9 Wardelmann E, Kuntze A, Trautmann M, Hartmann W. [Abdominal soft tissue tumors]. Pathologie (Heidelb) 2022;43:42-9. [PMID: 36222918 DOI: 10.1007/s00292-022-01128-7] [Reference Citation Analysis]
10 Frühwald MC, Bourdeaut F, Furtwängler R. Extracranial Rhabdoid Tumours. Pediatric Oncology 2022. [DOI: 10.1007/978-3-030-92071-5_34] [Reference Citation Analysis]
11 Dihowm H, Amin M, Ballentine S. SMARCB1(INI1)-deficient undifferentiated carcinoma with rhabdoid features of anorectal origin. Current Problems in Cancer: Case Reports 2021;4:100095. [DOI: 10.1016/j.cpccr.2021.100095] [Reference Citation Analysis]
12 Libera L, Ottini G, Sahnane N, Pettenon F, Turri-Zanoni M, Lambertoni A, Chiaravalli AM, Leone F, Battaglia P, Castelnuovo P, Uccella S, Furlan D, Facco C, Sessa F. Methylation Drivers and Prognostic Implications in Sinonasal Poorly Differentiated Carcinomas. Cancers (Basel) 2021;13:5030. [PMID: 34638515 DOI: 10.3390/cancers13195030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Thway K, Fisher C. Undifferentiated and dedifferentiated soft tissue neoplasms: Immunohistochemical surrogates for differential diagnosis. Semin Diagn Pathol 2021;38:170-86. [PMID: 34602314 DOI: 10.1053/j.semdp.2021.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Wakely PE Jr, Siddiqui MT. Fine-needle aspiration cytopathology of soft tissue myoepithelioma: an analysis of seven cases. J Am Soc Cytopathol 2021:S2213-2945(21)00255-6. [PMID: 34649776 DOI: 10.1016/j.jasc.2021.09.001] [Reference Citation Analysis]
15 Schwartz CJ, Pareja F, da Silva EM, Selenica P, Ross DS, Weigelt B, Brogi E, Reis-Filho JS, Wen HY. Histologic and genomic features of breast cancers with alterations affecting the SWI/SNF (SMARC) genes. Mod Pathol 2021;34:1850-9. [PMID: 34079072 DOI: 10.1038/s41379-021-00837-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Schaefer IM, Al-Ibraheemi A, Qian X. Cytomorphologic Spectrum of SMARCB1-Deficient Soft Tissue Neoplasms. Am J Clin Pathol 2021;156:229-45. [PMID: 33608696 DOI: 10.1093/ajcp/aqaa223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Gradecki SE, Kelting SM, Stelow EB. SMARCB1 (INI1)–Deficient Sinonasal Carcinoma With Yolk Sac Tumor Differentiation: Case Report and Review of the Literature. AJSP: Reviews and Reports 2021;26:259-263. [DOI: 10.1097/pcr.0000000000000456] [Reference Citation Analysis]
18 Hui Y, Cotzia P, Rana S, Kezlarian BE, Lin O, Hollmann TJ, Dogan S. Primary cutaneous SMARCB1-deficient carcinoma. J Cutan Pathol 2021;48:1051-60. [PMID: 33625734 DOI: 10.1111/cup.13996] [Reference Citation Analysis]
19 Agaimy A, Bishop JA. SWI/SNF-deficient head and neck neoplasms: An overview. Semin Diagn Pathol 2021;38:175-82. [PMID: 33663878 DOI: 10.1053/j.semdp.2021.02.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
20 Frühwald MC, Nemes K, Boztug H, Cornips MCA, Evans DG, Farah R, Glentis S, Jorgensen M, Katsibardi K, Hirsch S, Jahnukainen K, Kventsel I, Kerl K, Kratz CP, Pajtler KW, Kordes U, Ridola V, Stutz E, Bourdeaut F. Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group. Fam Cancer 2021. [PMID: 33532948 DOI: 10.1007/s10689-021-00229-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Mocellin S. Extraskeletal Myxoid Chondrosarcoma. Soft Tissue Tumors 2021. [DOI: 10.1007/978-3-030-58710-9_94] [Reference Citation Analysis]
22 Mocellin S. Rhabdoid Tumor. Soft Tissue Tumors 2021. [DOI: 10.1007/978-3-030-58710-9_222] [Reference Citation Analysis]
23 Mocellin S. SMARC-Deficient Sarcomas. Soft Tissue Tumors 2021. [DOI: 10.1007/978-3-030-58710-9_229] [Reference Citation Analysis]
24 Baraban E, Cooper K. Dedifferentiated and undifferentiated neoplasms: A conceptual approach. Semin Diagn Pathol 2020;:50682. [PMID: 32948384 DOI: 10.1053/j.semdp.2020.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
25 Early CA, Wangsiricharoen S, Jones RM, VandenBussche CJ. Review of SMARCA4 (BRG1)-deficient carcinomas following a malignant pleural effusion specimen confounded by reduced claudin-4 expression. J Am Soc Cytopathol 2021;10:197-207. [PMID: 32893180 DOI: 10.1016/j.jasc.2020.08.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
26 Wakely PE Jr. Extraskeletal myxoid chondrosarcoma: combining cytopathology with molecular testing to achieve diagnostic accuracy. J Am Soc Cytopathol 2021;10:293-9. [PMID: 32828707 DOI: 10.1016/j.jasc.2020.07.135] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Agaimy A, Jain D, Uddin N, Rooper LM, Bishop JA. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies. Am J Surg Pathol 2020;44:703-10. [PMID: 31934917 DOI: 10.1097/PAS.0000000000001428] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 15.3] [Reference Citation Analysis]
28 Schaefer IM, Hornick JL. SWI/SNF complex-deficient soft tissue neoplasms: An update. Semin Diagn Pathol 2021;38:222-31. [PMID: 32646614 DOI: 10.1053/j.semdp.2020.05.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
29 Choi JH, Ro JY. Epithelioid Cutaneous Mesenchymal Neoplasms: A Practical Diagnostic Approach. Diagnostics (Basel) 2020;10:E233. [PMID: 32316685 DOI: 10.3390/diagnostics10040233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mittal P, Roberts CWM. The SWI/SNF complex in cancer - biology, biomarkers and therapy. Nat Rev Clin Oncol 2020;17:435-48. [PMID: 32303701 DOI: 10.1038/s41571-020-0357-3] [Cited by in Crossref: 145] [Cited by in F6Publishing: 157] [Article Influence: 48.3] [Reference Citation Analysis]
31 Villatoro TM, Ma C, Pai RK. Switch/sucrose nonfermenting nucleosome complex-deficient colorectal carcinomas have distinct clinicopathologic features. Hum Pathol 2020;99:53-61. [PMID: 32222462 DOI: 10.1016/j.humpath.2020.03.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
32 Wakely PE Jr. Cytopathology of classic type epithelioid sarcoma: a series of 20 cases and review of the literature. J Am Soc Cytopathol 2020;9:126-36. [PMID: 32113803 DOI: 10.1016/j.jasc.2019.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
33 Agaimy A. What is new in epithelioid soft tissue tumors? Virchows Arch 2020;476:81-96. [PMID: 31686193 DOI: 10.1007/s00428-019-02677-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
34 Agaimy A. [Myxoid soft tissue tumours : An algorithm for differential diagnosis]. Pathologe 2019;40:353-65. [PMID: 31168638 DOI: 10.1007/s00292-019-0623-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
35 Kilic AI, Mirza K, Mehrotra S, Pambuccian SE. A BAFfling liver aspirate: Metastatic high grade SMARCA4 deficient undifferentiated gastroesophageal junction carcinoma masquerading as a hematolymphoid malignancy. Diagn Cytopathol 2019;47:725-32. [PMID: 30897306 DOI: 10.1002/dc.24174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]